Evidence map›Paper›PMID 27918450›Full record

ArticleMolecules (Basel, Switzerland)2016

Janus Compounds, 5-Chloro-N⁴-methyl-N⁴-aryl-9H-pyrimido[4,5-b]indole-2,4-diamines, Cause Both Microtubule Depolymerizing and Stabilizing Effects.

Cristina C Rohena, April L Risinger, Ravi Kumar Vyas Devambatla, Nicholas F Dybdal-Hargreaves, Roma Kaul, Shruti Choudhary, Aleem Gangjee, Susan L Mooberry

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Cristina C RohenaDepartment of Pharmacology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA. crohena@ucsd.edu.
April L RisingerDepartment of Pharmacology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA. risingera@uthscsa.edu.
Ravi Kumar Vyas DevambatlaDivision of Medicinal Chemistry, Graduate School of Pharmaceutical Sciences, Duquesne University, Pittsburgh, PA 15282, USA. drkvyas@gmail.com.
Nicholas F Dybdal-HargreavesDepartment of Pharmacology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA. hargreavesnd@livemail.uthscsa.edu.
Roma KaulDepartment of Pharmacology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA. kaulr@livemail.uthscsa.edu.
Shruti ChoudharyDivision of Medicinal Chemistry, Graduate School of Pharmaceutical Sciences, Duquesne University, Pittsburgh, PA 15282, USA. choudharys@duq.edu.
Aleem GangjeeDivision of Medicinal Chemistry, Graduate School of Pharmaceutical Sciences, Duquesne University, Pittsburgh, PA 15282, USA. gangjee@duq.edu.
Susan L MooberryDepartment of Pharmacology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA. mooberry@uthscsa.edu.

Funding

TISSUE CULTURE---COREP30CA054174 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Robin Jean Leach · 1991 to 2026
$59.1M
Institute for Integration of Medicine & Science: A Partnership to Improve HealthUL1TR001120 · NCATS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI CLARK, ROBERT A, HARGREAVES, KENNETH M · 2013 to 2017
$16.5M
Institutional Research Training GrantT32DE014318 · NIDCR · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Kenneth M Hargreaves · 2002 to 2026
$12.1M
Water Soluble Antimitotics That Circumvent Rumor ResistanceR01CA142868 · NCI · DUQUESNE UNIVERSITY · PI GANGJEE, ALEEM, MOOBERRY, SUSAN L · 2011 to 2015
$1.5M
Notch signaling and anticancer drug sensitivity in oral squamous cell carcinomaF30DE025535 · NIDCR · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI DYBDAL-HARGREAVES, NICHOLAS FRANCIS · 2015 to 2018
$197k
NCATS NIH HHS UL1 TR001120NCI NIH HHS P30 CA054174NCI NIH HHS R01 CA142868NIDCR NIH HHS F30 DE025535NIDCR NIH HHS T32 DE014318
6 · The paper itself

Abstract

While evaluating a large library of compounds designed to inhibit microtubule polymerization, we identified four compounds that have unique effects on microtubules. These compounds cause mixed effects reminiscent of both microtubule depolymerizers and stabilizers. Immunofluorescence evaluations showed that each compound initially caused microtubule depolymerization and, surprisingly, with higher concentrations, microtubule bundles were also observed. There were subtle differences in the propensity to cause these competing effects among the compounds with a continuum of stabilizing and destabilizing effects. Tubulin polymerization experiments confirmed the differential effects and, while each of the compounds increased the initial rate of tubulin polymerization at high concentrations, total tubulin polymer was not enhanced at equilibrium, likely because of the dueling depolymerization effects. Modeling studies predict that the compounds bind to tubulin within the colchicine site and confirm that there are differences in their potential interactions that might underlie their distinct effects on microtubules. Due to their dual properties of microtubule stabilization and destabilization, we propose the name Janus for these compounds after the two-faced Roman god. The identification of synthetically tractable, small molecules that elicit microtubule stabilizing effects is a significant finding with the potential to identify new mechanisms of microtubule stabilization.

Indexed as

Binding SitesCell Cycle CheckpointsCell Line, TumorCrystallography, X-RayDiaminesHeLa CellsHumansMicrotubulesModels, MolecularTubulinTubulin ModulatorsDiaminesTubulinTubulin Modulatorscancercolchicine sitemicrotubulemicrotubule destabilizermicrotubule stabilizer

Identifiers

PMID27918450
PMCPMC5470396

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.